The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curtsinger, J. M.
Right arrow Articles by Mescher, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtsinger, J. M.
Right arrow Articles by Mescher, M. F.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2005, 175: 4392-4399.
Copyright © 2005 by The American Association of Immunologists

Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis1

Julie M. Curtsinger2, Debra C. Lins, Christopher M. Johnson and Matthew F. Mescher

Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455

Naive CD8 T cells that respond in vivo to Ag and costimulation in the absence of a third signal, such as IL-12, fail to develop cytolytic function and become tolerized. We show in this study that CD8 T cells purified from TCR transgenic mice and stimulated in vitro in the presence or absence of IL-12 form conjugates with specific target cells, increase intracellular Ca2+, and undergo degranulation to comparable extents. Perforin is also expressed at comparable levels in the absence or presence of a third signal, but expression of granzyme B depends upon IL-12. Levels of granzyme B also correlate strongly with the cytolytic activity of cells responding in vivo. In contrast, an increase in CD107a (lysosomal-associated membrane protein 1) expression resulting from degranulation cannot distinguish in vivo generated lytic effector cells from tolerized, noncytolytic cells. Thus, it appears that cells rendered tolerant as a result of stimulation in the absence of a third signal fail to lyse target cells because they are "shooting blanks."




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Zhao, J. Zhao, and S. Perlman
De Novo Recruitment of Antigen-Experienced and Naive T Cells Contributes to the Long-Term Maintenance of Antiviral T Cell Populations in the Persistently Infected Central Nervous System
J. Immunol., October 15, 2009; 183(8): 5163 - 5170.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. McGill, J. W. Heusel, and K. L. Legge
Innate immune control and regulation of influenza virus infections
J. Leukoc. Biol., October 1, 2009; 86(4): 803 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Agarwal, A. Raghavan, S. L. Nandiwada, J. M. Curtsinger, P. R. Bohjanen, D. L. Mueller, and M. F. Mescher
Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory
J. Immunol., August 1, 2009; 183(3): 1695 - 1704.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. A. Parish, S. Rao, G. K. Smyth, T. Juelich, G. S. Denyer, G. M. Davey, A. Strasser, and W. R. Heath
The molecular signature of CD8+ T cells undergoing deletional tolerance
Blood, May 7, 2009; 113(19): 4575 - 4585.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. C. Zahn, M. D. Rett, B. Korioth-Schmitz, Y. Sun, A. P. Buzby, S. Goldstein, C. R. Brown, R. A. Byrum, G. J. Freeman, N. L. Letvin, et al.
Simian Immunodeficiency Virus (SIV)-Specific CD8+ T-Cell Responses in Vervet African Green Monkeys Chronically Infected with SIVagm
J. Virol., December 1, 2008; 82(23): 11577 - 11588.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Zheng, P. A. Cohen, C. A. Paustian, T. D. Johnson, W. T. Lee, S. Shu, and G. K. Koski
Paired Toll-like Receptor Agonists Enhance Vaccine Therapy through Induction of Interleukin-12
Cancer Res., June 1, 2008; 68(11): 4045 - 4049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Usharauli and T. Kamala
Brief Antigenic Stimulation Generates Effector CD8 T Cells with Low Cytotoxic Activity and High IL-2 Production
J. Immunol., April 1, 2008; 180(7): 4507 - 4513.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. C. Kemball, E. Szomolanyi-Tsuda, and A. E. Lukacher
Allogeneic Differences in the Dependence on CD4+ T-Cell Help for Virus-Specific CD8+ T-Cell Differentiation
J. Virol., December 15, 2007; 81(24): 13743 - 13753.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Zelinskyy, S. Balkow, S. Schimmer, T. Werner, M. M. Simon, and U. Dittmer
The Level of Friend Retrovirus Replication Determines the Cytolytic Pathway of CD8+ T-Cell-Mediated Pathogen Control
J. Virol., November 1, 2007; 81(21): 11881 - 11890.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Srinivasan and K. A. Frauwirth
Reciprocal NFAT1 and NFAT2 Nuclear Localization in CD8+ Anergic T Cells Is Regulated by Suboptimal Calcium Signaling
J. Immunol., September 15, 2007; 179(6): 3734 - 3741.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. A. Love, N. Grabie, P. Duramad, G. Stavrakis, A. Sharpe, and A. Lichtman
CTLA-4 Ablation and Interleukin-12 Driven Differentiation Synergistically Augment Cardiac Pathogenicity of Cytotoxic T Lymphocytes
Circ. Res., August 3, 2007; 101(3): 248 - 257.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Z. Xiao, J. M. Curtsinger, M. Prlic, S. C. Jameson, and M. F. Mescher
The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses
Int. Immunol., June 1, 2007; 19(6): 733 - 743.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Curtsinger, M. Y. Gerner, D. C. Lins, and M. F. Mescher
Signal 3 Availability Limits the CD8 T Cell Response to a Solid Tumor
J. Immunol., June 1, 2007; 178(11): 6752 - 6760.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Barbey, P. Baumgaertner, E. Devevre, V. Rubio-Godoy, L. Derre, G. Bricard, P. Guillaume, I. F. Luescher, D. Lienard, J.-C. Cerottini, et al.
IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells
J. Immunol., March 15, 2007; 178(6): 3566 - 3574.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. F. D'Orazio, M. J. Troese, and M. N. Starnbach
Cytosolic Localization of Listeria monocytogenes Triggers an Early IFN-{gamma} Response by CD8+ T Cells That Correlates with Innate Resistance to Infection
J. Immunol., November 15, 2006; 177(10): 7146 - 7154.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. T. Shen, J. S. Y. Ma, J. Mather, S. Vukmanovic, and S. Radoja
Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells
J. Leukoc. Biol., October 1, 2006; 80(4): 827 - 837.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. B. Frey and N. Monu
Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response
J. Leukoc. Biol., April 1, 2006; 79(4): 652 - 662.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.